pharmaceutical industry

Competition law vs patent rights: NCLAT rules CCI has no power to probe patented product disputes; upholds case against Swiss drugmaker Vifor

Photo of author
The NCLAT ruled that the CCI cannot investigate disputes concerning patented products, asserting the Patent Act’s precedence over the Competition Act. This decision dismissed an ...

Cipla’s leadership change: Achin Gupta to succeed Umang Vohra

Photo of author
A New Chapter for Cipla: Achin Gupta Takes the Helm Change is the only constant, especially in the fast-paced world of pharmaceuticals. And at Cipla, ...

‘To provide clarity on future governance’: Ozempic-maker Novo Nordisk to shake up board; move comes after 9,000 layoffs

Photo of author
Novo Nordisk Reshapes Its Leadership: Charting a Course for the Future The Danish pharmaceutical behemoth, Novo Nordisk, the name now synonymous with the groundbreaking weight-loss ...

Trump’s 100% tariffs on branded drugs: Indian generics spared but poses risks for pharma sector – Explained

Photo of author
US President Trump announced a 100% tariff on imported branded and patented pharmaceuticals starting October 2025, aiming to boost domestic manufacturing. Indian generic drug makers ...

US tariff heat: Fitch says Indian firms face limited direct hit; pharma sector seen at risk if duties widen

Photo of author
Fitch Ratings cautions that while Indian corporates have limited direct exposure to current US tariffs, sectors like pharmaceuticals could face risks if further measures are ...

Zydus Lifesciences Q1 net profit rises 3% to Rs 1,467 crore

Photo of author
Zydus Lifesciences: Steady Growth & a Future Focused on Innovation The pharmaceutical landscape is a constantly evolving arena, a complex dance between scientific breakthroughs, regulatory ...

Biocon Q1 net profit falls 95% to Rs 31 crore

Photo of author
Biocon’s consolidated net profit plummeted by 95% to Rs 31 crore in the June quarter, with total revenue declining to Rs 4,022 crore. Despite this, ...

Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman

Photo of author
Sun Pharma’s India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi. Shanghvi will transition to executive chairman, ...